Influences of bathing and hot weather on the pharmacokinetics of a new transdermal clonidine, M-5041T

被引:15
作者
Fujimura, A [1 ]
Sasaki, M [1 ]
Harada, K [1 ]
Kumagai, Y [1 ]
Ohashi, K [1 ]
Ebihara, A [1 ]
机构
[1] HAMAMATSU UNIV SCH MED, DEPT CLIN PHARMACOL, HAMAMATSU, SHIZUOKA 43131, JAPAN
关键词
D O I
10.1002/j.1552-4604.1996.tb04755.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The influences of bathing and hot weather on plasma concentrations of clonidine were examined during application of a new transdermal clonidine system, M-5041T, in eight healthy volunteers, An M-5041T patch containing 6 mg of clonidine was applied on the right chest for 96 hours during winter with or without bathing (40 degrees C for 5 minutes) and also during summer without bathing, Plasma concentrations and urinary excretion of clonidine were determined for a 160-hour period after application, Plasma concentrations of clonidine in the winter trials did not differ significantly with or without bathing, Plasma drug concentration as a whole was significantly higher in the summer trial than in the winter trial, however, The maximum plasma concentration (C-max), area under the plasma concentration-time curve (AUC), and urinary excretion (Ae) of clonidine also tended to be higher in the summer trial. These results suggest that plasma levels of clonidine are higher after application of M-5041T during hot weather. Although the period of bathing used in this study was short, the influence of bathing seems to be negligible.
引用
收藏
页码:892 / 896
页数:5
相关论文
共 10 条
  • [1] PHARMACOKINETICS AND PHARMACODYNAMICS OF A NEW TRANSDERMAL CLONIDINE, M-5041T, IN HEALTHY-SUBJECTS
    FUJIMURA, A
    EBIHARA, A
    SHIGA, T
    KUMAGAI, Y
    OHASHI, K
    NAKASHIMA, H
    KOTEGAWA, T
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (12) : 1192 - 1200
  • [2] TRANSDERMAL CLONIDINE APPLICATION - LONG-TERM RESULTS IN ESSENTIAL-HYPERTENSION
    GROTH, H
    VETTER, H
    KNUSEL, J
    FOERSTER, E
    SIEGENTHALER, W
    VETTER, W
    [J]. KLINISCHE WOCHENSCHRIFT, 1984, 62 (19): : 925 - 930
  • [3] HAYAKAWA R, 1991, SKIN RES, V33, P356
  • [4] CLONIDINE HYDROCHLORIDE - REVIEW OF PHARMACOLOGIC AND CLINICAL ASPECTS
    HOUSTON, MC
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1981, 23 (05) : 337 - 350
  • [5] PERCUTANEOUS ABSORPTION
    IDSON, B
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (06) : 901 - 924
  • [6] TRANSDERMAL CLONIDINE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY
    LANGLEY, MS
    HEEL, RC
    [J]. DRUGS, 1988, 35 (02) : 123 - 142
  • [7] PHARMACOKINETICS OF CLONIDINE
    LOWENTHAL, DT
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1980, 2 : S29 - S37
  • [8] ORAL SUBSTITUTION IN PATIENTS SENSITIZED BY TRANSDERMAL CLONIDINE TREATMENT
    MAIBACH, HI
    [J]. CONTACT DERMATITIS, 1987, 16 (01) : 1 - 8
  • [9] NAKASHIMA M, 1987, JPN J CLIN PHARM, V18, P627
  • [10] EVALUATION OF THE SKIN SURFACE HYDRATION INVIVO BY ELECTRICAL MEASUREMENT
    TAGAMI, H
    OHI, M
    IWATSUKI, K
    KANAMARU, Y
    YAMADA, M
    ICHIJO, B
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1980, 75 (06) : 500 - 507